disclaimer

Peptide stack builder

Build a peptide stack for your research goal. Protocol tables with complementary mechanisms, dosing, timing, and role β€” for fat loss, tissue healing, growth hormone optimization, and more.

Peptide stacking is the practice of combining multiple peptides in a single research protocol to address complementary biological pathways simultaneously. The key principle is complementarity β€” effective stacks target different mechanisms, not the same one twice.

Combining two GLP-1 agonists provides no additive benefit because they compete for the same receptors. Combining BPC-157 and TB-500, by contrast, is synergistic: BPC-157 works through growth hormone receptor upregulation and nitric oxide signaling; TB-500 acts through actin regulation and cell migration. Together they address multiple steps in the tissue repair cascade that neither covers alone.

Timing design is a critical aspect of stacking that is often overlooked. Peptides with short half-lives (BPC-157: 4 hours, sermorelin: 10 minutes, ipamorelin: 2 hours) require multiple daily doses to maintain active compound. Peptides with long half-lives (tirzepatide: 120 hours, TB-500: 5 days, CJC-1295 with DAC: 8 days) are dosed once weekly or twice weekly. A well-designed stack accounts for these pharmacokinetic differences.

This builder provides pre-validated stack protocols for six common research goals: fat loss, healing and recovery, growth hormone optimization, tendon repair, general longevity, and metabolic health. Each stack includes the peptide name, dose, timing, and mechanistic role. Protocols are based on published pharmacokinetic data and established research practices.

For research use only. Individual responses vary. All peptides should be sourced from verified research chemical suppliers with certificate of analysis documentation.

calc.selectGoal

calc.recommendedStack

calc.peptidecalc.dosecalc.timingcalc.role
BPC-157250–500 mcg2Γ— daily (AM/PM)Primary
TB-5002.5–5 mg2Γ— per weekSynergist
GHK-Cu2 mg3Γ— per weekOptional

BPC-157 + TB-500 is the most studied combo for tendon and muscle repair. GHK-Cu adds skin and collagen benefits.

toolShell.disclaimer

Frequently asked questions

Can I stack BPC-157 and TB-500 together for tendon repair?+

Yes β€” BPC-157 and TB-500 is the most researched peptide combination for tendon and connective tissue repair. They work via distinct mechanisms: BPC-157 through growth hormone receptor upregulation in tendon fibroblasts and nitric oxide-mediated angiogenesis; TB-500 through thymosin beta-4 actin regulation promoting cell migration into the injury site. A typical protocol is BPC-157 250-500 mcg twice daily (local injection near injury) + TB-500 2-5mg twice weekly (systemic injection).

Can I stack retatrutide with BPC-157 for simultaneous fat loss and healing?+

Yes β€” retatrutide and BPC-157 operate through entirely different receptor systems with no known negative interaction. Retatrutide acts on GIP, GLP-1, and glucagon receptors for metabolic effects; BPC-157 acts on growth hormone receptors and the nitric oxide system for tissue repair. Many researchers combine GLP-1 agonists with healing peptides when both metabolic and recovery goals are present. Monitor liver enzymes given retatrutide's hepatic fat mobilization effects.

What peptides work well with CJC-1295 for growth hormone optimization?+

Ipamorelin is the standard combination partner for CJC-1295. CJC-1295 is a GHRH analogue that stimulates the pituitary to produce and release growth hormone. Ipamorelin is a selective GHRP (growth hormone releasing peptide) that triggers GH release through a different receptor. Together they produce a larger GH pulse than either alone. A typical protocol is CJC-1295 (no DAC) 100mcg + ipamorelin 200mcg, co-administered before sleep.

How do I time multiple peptide injections in a single day?+

Group short half-life peptides (ipamorelin, sermorelin, BPC-157) at the same injection time when possible to minimize needle frequency. Pre-sleep is optimal for GH peptides due to the natural GH pulse during slow-wave sleep. BPC-157 is typically dosed morning and evening. Tirzepatide and retatrutide are once-weekly and can be administered any consistent day. Rotate injection sites to avoid tissue buildup at any single location.

Is it safe to use multiple peptides simultaneously?+

The peptides in this stack builder have distinct mechanisms and target different receptor systems, reducing the risk of receptor competition or additive adverse effects. That said, combining any agents introduces complexity in assessing causality if side effects occur. Start new peptides one at a time, allow 2 weeks of observation, then add the next. This makes it easier to identify which peptide is responsible if an adverse reaction occurs. All stacking is for research purposes only.

email.title

email.subtitle